Professor Gerald Holtmann
Professor

Gerald Holtmann

Email: 
Phone: 
+61 7 3176 7792

Background

Prof Holtmann is a Clinical Academic in the field of Gastroenterology & Hepatology and Director of Clinical Innovation. He is also Director of the Department of Gastroenterology & Hepatology at the Princess Alexandra Hospital in Queensland and serves on the Board of Directors of the West Moreton Hospital and Health Service and UQ Healthcare. He is a Fellow of Royal Australian Collge of Physicians (RACP, Sydney), the Royal College of Physicians (RCP, London) and Fellow of the Australian Academy of Health and Medical Sciences (AAHMS, Canberra). Besides his Medical Qualifications he also obtained a Master of Business Administration. After completing the clinical training in Medicine and Gastroenterology at the University of Essen in Germany and the Mayo Clinic in Rochester, Minnesota in the United States, he has gained substantial leadership and managerial experience within the health care setting as Director of large Gastroenterology Departments, CEO and General Manager of a University Hospital and Health Care Facilities and has served on the Board of the University Hospital Essen in Germany. His research is in the field of Neurogastroenterology has resulted in peer reviewed publications in key journal including the NEJM, Lancet, Gastroenterology and Gut. More recently his rersearch focus is on the role of the gut microbiome, mucosal and systemic inflammation and brain-gut interactions.

Availability

Professor Gerald Holtmann is:
Available for supervision
Media expert

Search Professor Gerald Holtmann’s works on UQ eSpace

539 works between 1986 and 2025
All (539) Journal Article (403) Book Chapter (4) Conference Publication (132)

301 - 320 of 539 works

2012

Conference Publication

IBS: genes versus the environment

Holtmann, Gerald (2012). IBS: genes versus the environment. Asian Pacific Digestive Week 2012, Bangkok, Thailand, 05-08 December 2012. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12005

IBS: genes versus the environment

2012

Conference Publication

What is the unmet need in patients with inflammatory bowel disease and is this linked to inflammatory activity?

Greis, Christian, Mayer, Nora, Hendy, Peter, Burger, Daniel, Martin, Neal, Young, Louise and Holtmann, Gerald (2012). What is the unmet need in patients with inflammatory bowel disease and is this linked to inflammatory activity?. Australian Gastroenterology Week 2012, Adelaide, SA, Australia, 16-19 October 2012. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_6.x

What is the unmet need in patients with inflammatory bowel disease and is this linked to inflammatory activity?

2012

Journal Article

Carbon-based compounds emerging as sparkling diamonds for IBS treatment?

Chao, C. Y. and Holtmann, G. J. (2012). Carbon-based compounds emerging as sparkling diamonds for IBS treatment?. Alimentary Pharmacology and Therapeutics, 35 (1), 199-200. doi: 10.1111/j.1365-2036.2011.04893.x

Carbon-based compounds emerging as sparkling diamonds for IBS treatment?

2012

Conference Publication

Does urgency categorisation (triaging) prevent delayed diagnoses and treatment of significant gastric and colonic disease?

Black, Marrianne, Ward, Cheryl, Hourigan, Luke F., Appleyard, Mark N. and Holtmann, Gerald (2012). Does urgency categorisation (triaging) prevent delayed diagnoses and treatment of significant gastric and colonic disease?. Digestive Disease Week (DDW), San Diego, CA, United States, 19-22 May 2012. Philadelphia, PA, United States: Mosby. doi: 10.1016/j.gie.2012.03.759

Does urgency categorisation (triaging) prevent delayed diagnoses and treatment of significant gastric and colonic disease?

2012

Conference Publication

Mechanisms of FD: what is the role of motor, sensory and inflammatory disorders?

Holtmann, Gerald (2012). Mechanisms of FD: what is the role of motor, sensory and inflammatory disorders?. Asian Pacific Digestive Week 2012, Bangkok, Thailand, 05-08 December 2012. Richmond, VIC., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/jgh.12005

Mechanisms of FD: what is the role of motor, sensory and inflammatory disorders?

2012

Conference Publication

Empirical third line H. pylori eradication therapy: a meta-analysis

Hendy, Peter J. and Holtmann, Gerald (2012). Empirical third line H. pylori eradication therapy: a meta-analysis. Australian Gastroenterology Week 2012, Adelaide, SA, Australia, 16-19 October 2012. Richmond, VIC, Australia: Wiley-Blackwell. doi: 10.1111/j.1440-1746.2011.07251_7.x

Empirical third line H. pylori eradication therapy: a meta-analysis

2012

Journal Article

Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes

Hughes, P.A., Harrington, A.M., Castro, J., Liebregts, T., Adam, B., Grasby, D.J., Isaacs, N.J., Maldeniya, L., Martin, C.M., Persson, J., Andrews, J.M., Holtmann, G., Blackshaw, A.L. and Brierley, S.M. (2012). Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes. Gut, 62 (10), 1456-1465. doi: 10.1136/gutjnl-2011-301856

Sensory neuro-immune interactions differ between Irritable Bowel Syndrome subtypes

2011

Journal Article

Helicobacter pylori eradication and weight gain: has it opened a Pandora's box?

Chacko, Y. and Holtmann, G. J. (2011). Helicobacter pylori eradication and weight gain: has it opened a Pandora's box?. Alimentary Pharmacology and Therapeutics, 34 (2), 256-256. doi: 10.1111/j.1365-2036.2011.04704.x

Helicobacter pylori eradication and weight gain: has it opened a Pandora's box?

2011

Journal Article

Is there an association between hospital accreditation and patient satisfaction with hospital care? A survey of 37 000 patients treated by 73 hospitals

Sack, C., Scherag, A., Luetkes, P., Guenther, W., Joeckel, K. -H. and Holtmann, G. (2011). Is there an association between hospital accreditation and patient satisfaction with hospital care? A survey of 37 000 patients treated by 73 hospitals. International Journal for Quality in Health Care, 22 (3) mzr011, 278-283. doi: 10.1093/intqhc/mzr011

Is there an association between hospital accreditation and patient satisfaction with hospital care? A survey of 37 000 patients treated by 73 hospitals

2011

Journal Article

Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia

Liebregts, Tobias, Adam, Birgit, Bredack, Christoph, Gururatsakul, Montri, Pilkington, Katherine R., Brierley, Stuart M., Blackshaw, L. Ashley, Gerken, Guido, Talley, Nicholas J. and Holtmann, Gerald (2011). Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia. American Journal of Gastroenterology, 106 (6), 1089-1098. doi: 10.1038/ajg.2010.512

Small bowel homing T cells are associated with symptoms and delayed gastric emptying in functional dyspepsia

2011

Journal Article

Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD

Holtmann, Gerald, Bigard, Marc-Andre, Malfertheiner, Peter and Pounder, Roy (2011). Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD. International Journal of Clinical Pharmacy, 33 (3), 493-500. doi: 10.1007/s11096-011-9489-y

Guidance on the use of over-the-counter proton pump inhibitors for the treatment of GERD

2011

Journal Article

Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status

Bryant, Robert V., van Langenberg, Daniel R., Holtmann, Gerald J. and Andrews, Jane M. (2011). Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status. Journal of Gastroenterology and Hepatology, 26 (5), 916-923. doi: 10.1111/j.1440-1746.2011.06624.x

Functional gastrointestinal disorders in inflammatory bowel disease: Impact on quality of life and psychological status

2011

Journal Article

A 13-nation population survey of upper gastrointestinal symptoms: Prevalence of symptoms and socioeconomic factors

Haag, S., Andrews, J. M., Gapasin, J., Gerken, G., Keller, A. and Holtmann, G. J. (2011). A 13-nation population survey of upper gastrointestinal symptoms: Prevalence of symptoms and socioeconomic factors. Alimentary Pharmacology and Therapeutics, 33 (6), 722-729. doi: 10.1111/j.1365-2036.2010.04564.x

A 13-nation population survey of upper gastrointestinal symptoms: Prevalence of symptoms and socioeconomic factors

2011

Journal Article

Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) 1

Layer, P., Andresen, V., Pehl, C., Allescher, H., Bischoff, S. C., Claßen, M., Enck, P., Frieling, T., Haag, S., Holtmann, G., Karaus, M., Kathemann, S., Keller, J., Kuhlbusch-Zicklam, R., Kruis, W., Langhorst, J., Matthes, H., Mönnikes, H., Müller-Lissner, S., Musial, F., Otto, B., Rosenberger, C., Schemann, M., Van Der Voort, I., Dathe, K. and Preiß, J. C. (2011). Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) 1. Zeitschrift fur Gastroenterologie, 49 (2), 237-293. doi: 10.1055/s-0029-1245976

Irritable bowel syndrome: German consensus guidelines on definition, pathophysiology and management S3-Leitlinie Reizdarmsyndrom: Definition, Pathophysiologie, Diagnostik und Therapie. Gemeinsame Leitlinie der Deutschen Gesellschaft für Verdauungs- und Stoffwechselkrankheiten (DGVS) und der Deutschen Gesellschaft für Neurogastroenterologie und Motilität (DGNM) 1

2011

Journal Article

Itopride in the treatment of functional dyspepsia in Chinese patients: A prospective, multicentre, post-marketing observational study

Sun, Jing, Yuan, Yao-Zong and Holtmann, Gerald (2011). Itopride in the treatment of functional dyspepsia in Chinese patients: A prospective, multicentre, post-marketing observational study. Clinical Drug Investigation, 31 (12), 865-875. doi: 10.2165/11593290-000000000-00000

Itopride in the treatment of functional dyspepsia in Chinese patients: A prospective, multicentre, post-marketing observational study

2011

Journal Article

An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation

Mikocka-Walus, Antonina A., Turnbull, Deborah, Holtmann, Gerald and Andrews, Jane M. (2011). An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation. Inflammatory Bowel Diseases, 18 (8), 1573-1581. doi: 10.1002/ibd.22850

An integrated model of care for inflammatory bowel disease sufferers in Australia: Development and the effects of its implementation

2011

Journal Article

A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease

Sack, C., Phan, V.A., Grafton, R., Holtmann, G., van Langenberg, D.R., Brett, K., Clark, M. and Andrews, J.M. (2011). A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease. Journal of Crohn's and Colitis, 6 (3), 302-310. doi: 10.1016/j.crohns.2011.08.019

A chronic care model significantly decreases costs and healthcare utilisation in patients with inflammatory bowel disease

2011

Conference Publication

Is the decrease of H. pylori associated with endemic obesity in the western world?

Lenders, N. F. and Holtmann, G. (2011). Is the decrease of H. pylori associated with endemic obesity in the western world?. Australian Gastroenterology Week 2011, Brisbane, Qld, Australia, 12–15 September, 2011. Richmond, Vic., Australia: Wiley-Blackwell Publishing Asia. doi: 10.1111/j.1440-1746.2011.06825.x

Is the decrease of H. pylori associated with endemic obesity in the western world?

2011

Journal Article

IBD: Stress causes flares of IBD-how much evidence is enough?

Andrews, Jane M. and Holtmann, Gerald (2011). IBD: Stress causes flares of IBD-how much evidence is enough?. Nature Reviews Gastroenterology and Hepatology, 8 (1), 13-14. doi: 10.1038/nrgastro.2010.208

IBD: Stress causes flares of IBD-how much evidence is enough?

2011

Journal Article

Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: Are G-protein beta 3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?

Holtmann, G., van Rensburg, C., Schwan, T., Sander, P. and Siffert, W. (2011). Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: Are G-protein beta 3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?. Digestion, 84 (4), 289-298. doi: 10.1159/000331468

Improvement of non-steroidal anti-inflammatory drug-induced gastrointestinal symptoms during proton pump inhibitor treatment: Are G-protein beta 3 subunit genotype, Helicobacter pylori status, and environmental factors response modifiers?

Current funding

  • 2022 - 2026
    ARC Training Centre for Behavioural Insights for Technology Adoption (BITA) (ARC Industrial Transformation Training Centre Administered by QUT)
    Queensland University of Technology
    Open grant
  • 2021 - 2025
    A practice change for patients with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled intervention to assess efficacy and cost-effectiveness
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2020 - 2024
    Modulation of the Gastrointestinal Microbiome with probiotics and subsequent Methane production as a novel approach to treat constipation: A Proof of Principle Study (TRI Sport Grant led by PAH)
    Metro South Hospital and Health Service
    Open grant
  • 2020 - 2025
    Targeting the gut microbiome as a treatment for Primary Sclerosing Cholangitis: The Queensland Clinical Network Study
    NHMRC MRFF - Rare Cancers, Rare Diseases and Unmet Need
    Open grant
  • 2019 - 2024
    Centre for Research Excellence in Digestive Health (NHMRC CRE administered by University of Newcastle)
    University of Newcastle
    Open grant
  • 2016
    Establishing a gnotobiotic germ-free mouse facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2016
    The Australian human microbiota project-microbe isolation facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015 - 2018
    Pathophysiology of functional dyspepsia: Integration of upper gut function, inflammation and a systems biology approach.
    NHMRC Project Grant
    Open grant
  • 2014 - 2017
    Functional dyspepsia: Characterisation of the immunopathology and testing a novel therapeutic strategy (NHMRC Project Grant administered by the University of Newcastle)
    University of Newcastle
    Open grant

Availability

Professor Gerald Holtmann is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Supervision history

Current supervision

  • Doctor Philosophy

    Reimagining Health Equity and Access in Colorectal Cancer Screening. A population perspective.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    IBD and mental health tools: a holistic approach to discovery and appropriate tool.

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Effects the COVID-19 pandemic on the outcome and management of highly prevalent gastrointestinal conditions

    Principal Advisor

    Other advisors: Dr Ayesha Shah

  • Doctor Philosophy

    Study of TOfacitinib for the treatment of chronic Pouchitis

    Associate Advisor

    Other advisors: Associate Professor Jakob Begun

  • Doctor Philosophy

    Exercise training on people with severe chronic, clinically unexplained gastrointestinal symptoms: A randomised, controlled trial.

    Associate Advisor

    Other advisors: Professor Jeff Coombes

  • Doctor Philosophy

    The role of the gut microbiome in alcohol related liver disease

    Associate Advisor

    Other advisors: Professor Jason Connor, Dr Paul Clark

Completed supervision

Enquiries

Contact Professor Gerald Holtmann directly for media enquiries about:

  • colon cancer screening
  • Gastroenterology
  • Gut Health
  • Microbiome
  • Neurogastroenterology

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au